Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine
暂无分享,去创建一个
D. Hoyer | T. Bártfai | M. C. Morale | G. Bilbe | P. Sanna | B. Conti | R. Maier | A. Barr | B Conti | D Hoyer | P P Sanna | G Bilbe | R Maier | A M Barr | M C Morale | X Lu | T Bartfai | T. Bártfai | X. Lu | Xiaoying Lu | M. Morale | X. Lu | X. Lu
[1] T. Sugimura,et al. Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. , 1991, Oncogene.
[2] K. Matsubara,et al. Psychophysiological stress‐regulated gene expression in mice , 2005, FEBS letters.
[3] E. Nestler,et al. Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures , 2004, The Journal of Neuroscience.
[4] S. Hyman,et al. A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation , 1998, The Journal of Neuroscience.
[5] Shannon McWeeney,et al. Deoxyribonucleic acid microarray analysis of gene expression pattern in the arcuate nucleus/ventromedial nucleus of hypothalamus during lactation. , 2005, Endocrinology.
[6] K. Perry,et al. R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study , 2002, Neuropsychopharmacology.
[7] A. Russo-Neustadt,et al. Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical Exercise , 2004, Neuropsychopharmacology.
[8] M. Hotopf,et al. Fluoxetine dose and outcome in antidepressant drug trials , 2002, European Journal of Clinical Pharmacology.
[9] H. Giedke,et al. Therapeutic sleep deprivation in depressives, restricted to the two nocturnal hours between 3:00 and 5:00 , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[10] F. E. Miller. Strategies for the rapid treatment of depression , 2001, Human psychopharmacology.
[11] M. Chen,et al. Brain-derived neurotrophic factor and antidepressant activity. , 2005, Current pharmaceutical design.
[12] M. Živin,et al. Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats. , 2002, Molecular pharmacology.
[13] W. Chapman,et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.
[14] R. Duman,et al. Role of neurotrophic factors in the etiology and treatment of mood disorders , 2007, NeuroMolecular Medicine.
[15] Deanna R. Brickley,et al. Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer. , 2005, European journal of cancer.
[16] Dan J Stein,et al. Social anxiety disorder , 2008, The Lancet.
[17] S. Kapur,et al. Electroconvulsive shock increases tyrosine hydroxylase and neuropeptide Y gene expression in the locus coeruleus. , 1993, Brain research. Molecular brain research.
[18] P. Cowen,et al. Brain 5-HT neurotransmission during paroxetine treatment , 1998, British Journal of Psychiatry.
[19] M. Gorfine,et al. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy , 1995, Psychopharmacology.
[20] I. Mizuta,et al. Infarct tolerance accompanied enhanced BDNF-like immunoreactivity in neuronal nuclei , 2000, Brain Research.
[21] A. Niculescu. Genomic studies of mood disorders - the brain as a muscle? , 2005, Genome Biology.
[22] V. Bader,et al. Sgk1, a cell survival response in neurodegenerative diseases , 2005, Molecular and Cellular Neuroscience.
[23] P. Worley,et al. Homer Proteins Regulate Sensitivity to Cocaine , 2004, Neuron.
[24] K. Simansky,et al. Serotonergic control of the organization of feeding and satiety , 1995, Behavioural Brain Research.
[25] G. Biggio,et al. Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain , 2001, Psychopharmacology.
[26] J. Meier,et al. GluR‐ and TrkB‐mediated maturation of GABAA receptor function during the period of eye opening , 2005, The European journal of neuroscience.
[27] J. Loffing,et al. Sgk kinases and their role in epithelial transport. , 2006, Annual review of physiology.
[28] P. Soubrié,et al. Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain. , 2002, Molecular pharmacology.
[29] R. Duman,et al. Antidepressants and neuroplasticity. , 2002, Bipolar disorders.
[30] J. R. Painter,et al. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. , 1998, The American journal of psychiatry.
[31] R. Hen,et al. Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test , 2005, Neuroscience & Biobehavioral Reviews.
[32] M. Tohyama,et al. Differential expression of sgk mRNA, a member of the Ser/Thr protein kinase gene family, in rat brain after CNS injury. , 1994, Brain research. Molecular brain research.
[33] P. Worley,et al. Synaptic Activity-Induced Conversion of Intronic to Exonic Sequence in Homer 1 Immediate Early Gene Expression , 2002, The Journal of Neuroscience.
[34] M. Sasa,et al. Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. , 1999, Japanese journal of pharmacology.
[35] W. Abraham,et al. Krox20 may play a key role in the stabilization of long-term potentiation. , 1995, Brain research. Molecular brain research.
[36] D. Nutt,et al. Invited review: the evolution of antidepressant mechanisms , 2004, Fundamental & clinical pharmacology.
[37] E G Jones,et al. Dysregulation of the fibroblast growth factor system in major depression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Schneider-Maunoury,et al. Krox-20 controls myelination in the peripheral nervous system , 1994, Nature.
[39] Pedro Parraguez Ruiz,et al. Termination of Psychotherapy: A Training Perspective , 2000, Journal of psychiatric practice.
[40] M Briley,et al. Neurobiological mechanisms involved in antidepressant therapies. , 1993, Clinical neuropharmacology.
[41] Huda Akil,et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. , 2003, The American journal of psychiatry.
[42] J. Adrien. Neurobiological bases for the relation between sleep and depression. , 2002, Sleep medicine reviews.
[43] H. Giedke,et al. Therapeutic use of sleep deprivation in depression. , 2002, Sleep medicine reviews.
[44] J. R. Painter,et al. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. , 2000, Journal of affective disorders.
[45] E. Nishida,et al. The ERK MAP kinase pathway mediates induction of SGK (serum‐ and glucocorticoid‐inducible kinase) by growth factors , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[46] C. Beverley,et al. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. , 2005, Health technology assessment.
[47] D. B. Clarke,et al. Administration of brain-derived neurotrophic factor suppresses the expression of heat shock protein 27 in rat retinal ganglion cells following axotomy , 2003, Neuroscience.
[48] P. Worley,et al. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia , 2005, Genes, brain, and behavior.
[49] C. Barsano,et al. Metabolic implications of low-dose triiodothyronine administration in rats: Relevance to the adjunctive use of triiodothyronine in the treatment of depression , 1994, Biological Psychiatry.
[50] A. Bird,et al. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. , 2005, Human molecular genetics.
[51] E. Rüther,et al. Anhedonia and motivational deficits in rats: Impact of chronic social stress , 2005, Behavioural Brain Research.
[52] G. Chiappetta,et al. Presence of physiologically stimulated RET in adult rat brain: induction of RET expression during nerve regeneration. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[53] P. Gass,et al. Mutant mouse models of depression: Candidate genes and current mouse lines , 2005, Neuroscience & Biobehavioral Reviews.
[54] W. Riedel,et al. Monoamine depletion in psychiatric and healthy populations: review , 2003, Molecular Psychiatry.
[55] K. Giese,et al. Memory Reconsolidation Engages Only a Subset of Immediate-Early Genes Induced during Consolidation , 2005, The Journal of Neuroscience.
[56] J. McGinty,et al. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. , 2002, Brain research. Gene expression patterns.
[57] N. Schork,et al. Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.
[58] J. Kelsoe,et al. Finding Genes for Bipolar Disorder in the Functional Genomics Era: From Convergent Functional Genomics to Phenomics and Back , 2002, CNS Spectrums.
[59] Diurnal effects of enriched environment on immediate early gene expression in the rat brain , 2005, Brain Research.
[60] H. Calil. Fluoxetine: a suitable long-term treatment. , 2001, The Journal of clinical psychiatry.
[61] C. Thompson. Onset of action of antidepressants: results of different analyses , 2002, Human psychopharmacology.
[62] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[63] B. Hoebel,et al. Hypothalamic serotonin in treatments for feeding disorders and depression as studied by brain microdialysis. , 1991, Journal of Clinical Psychiatry.
[64] C. Mucignat-Caretta,et al. Animal models of depression: olfactory lesions affect amygdala, subventricular zone, and aggression , 2004, Neurobiology of Disease.
[65] T. Visser,et al. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. , 2001, The Journal of clinical endocrinology and metabolism.
[66] M. Coughtrie,et al. Sulfation of apomorphine by human sulfotransferases: evidence of a major role for the polymorphic phenol sulfotransferase, SULT1A1 , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[67] H. Kung,et al. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. , 1995, The Journal of pharmacology and experimental therapeutics.
[68] I. Shimokawa,et al. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors. , 1995, Pathology, research and practice.
[69] S. Lisanby,et al. Neurogenesis and Depression , 2000, Journal of psychiatric practice.
[70] Z. Janka,et al. Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram. , 2004, The international journal of neuropsychopharmacology.
[71] T. Porkka-Heiskanen,et al. Noradrenergic activity in rat brain during rapid eye movement sleep deprivation and rebound sleep. , 1995, The American journal of physiology.
[72] A. Rossi,et al. Fluoxetine: a review on evidence based medicine , 2004, Annals of general hospital psychiatry.
[73] V. Ganapathy,et al. Antidepressant effects on kinase gene expression patterns in rat brain , 2002, Neuroscience Letters.
[74] F. Lang,et al. Stimulation of the EAAT4 glutamate transporter by SGK protein kinase isoforms and PKB. , 2004, Biochemical and biophysical research communications.
[75] Robert L. Phillips,et al. Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex , 2005, Neuron.
[76] M. Jouvet,et al. Alterations in c-fos expression after different experimental procedures of sleep deprivation in the cat , 1996, Brain Research.
[77] M. Markianos,et al. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course , 2002, European Archives of Psychiatry and Clinical Neuroscience.
[78] M. Åsberg,et al. "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.
[79] M. Owens. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. , 2004, The Journal of clinical psychiatry.
[80] P. Castrogiovanni,et al. Plasma Catecholamine Levels after Fluoxetine Treatment in Depressive Patients , 2005, Neuropsychobiology.
[81] Matthew L. Ho,et al. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. , 2003, The American journal of psychiatry.
[82] Russo-Neustadt Aa,et al. Brain-derived neurotrophic factor and antidepressant activity. , 2005, Current pharmaceutical design.
[83] Kei Yamamoto,et al. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain , 2000, Brain Research.
[84] C. Montigny,et al. Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.
[85] Andrew Lemire,et al. Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways , 2004, The Journal of Neuroscience.
[86] R. Kalb,et al. Serum/glucocorticoid‐inducible kinase can phosphorylate the cyclic AMP response element binding protein, CREB , 2005, FEBS letters.
[87] B. Engels,et al. Kainate-elicited seizures induce mRNA encoding a CaMK-related peptide: a putative modulator of kinase activity in rat hippocampus. , 1999, Journal of neurobiology.
[88] R. Fuller. Serotonergic stimulation of pituitary-adrenocortical function in rats. , 1981, Neuroendocrinology.
[89] E. Fähndrich. Effect of sleep deprivation as a predictor of treatment response to antidepressant medication , 1983, Acta psychiatrica Scandinavica.
[90] Sue J. Wilson,et al. Antidepressants and sleep: a qualitative review of the literature. , 2005, Drugs.
[91] J. Kennedy,et al. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood‐onset mood disorders , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[92] D. Overstreet,et al. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. , 2004, European journal of pharmacology.
[93] A. Bal-Klara. Effects of some antidepressant drugs on the activity of glial cell enzymes in culture. , 1989, European Journal of Pharmacology.
[94] T. Ito,et al. A novel G-protein-coupled receptor gene expressed in striatum. , 2000, Genomics.
[95] F. Angelucci,et al. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. , 2004, Progress in brain research.
[96] A. C. Maiyar,et al. Serum and glucocorticoid‐inducible kinase (SGK) is a target of the PI 3‐kinase‐stimulated signaling pathway , 1999, The EMBO journal.
[97] A. Mørk,et al. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels , 2004, Brain Research.
[98] D. Wong,et al. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex , 2002, Psychopharmacology.
[99] K. Inokuchi,et al. Identification and Cataloging of Genes Induced by Long‐Lasting Long‐Term Potentiation in Awake Rats , 2000, Journal of neurochemistry.
[100] S. Asai,et al. Alteration of serum/glucocorticoid regulated kinase-1 (sgk-1) gene expression in rat hippocampus after transient global ischemia. , 2004, Brain research. Molecular brain research.
[101] Y. L. Ma,et al. Enrichment enhances the expression of sgk, a glucocorticoid‐induced gene, and facilitates spatial learning through glutamate AMPA receptor mediation , 2003, The European journal of neuroscience.
[102] M. Knox,et al. Exercise‐induced gene expression in soleus muscle is dependent on time after spinal cord injury in rats , 2004, Muscle & nerve.
[103] Johan Bengzon,et al. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment , 2002, The European journal of neuroscience.
[104] K. Tsai,et al. sgk, a primary glucocorticoid-induced gene, facilitates memory consolidation of spatial learning in rats , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[105] O. Reiner,et al. Alternative Splice Variants of Doublecortin-like Kinase Are Differentially Expressed and Have Different Kinase Activities* , 2002, The Journal of Biological Chemistry.
[106] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[107] A. Sattin. The role of TRH and related peptides in the mechanism of action of ECT. , 1999, The journal of ECT.
[108] R. Dempsey,et al. Traumatic brain injury‐induced acute gene expression changes in rat cerebral cortex identified by GeneChip analysis , 2003, Journal of neuroscience research.
[109] B. Mallick,et al. Increased levels of tyrosine hydroxylase and glutamic acid decarboxylase in locus coeruleus neurons after rapid eye movement sleep deprivation in rats , 2003, Neuroscience Letters.
[110] L. Lanfumey,et al. 5-HT-HPA Interactions in Two Models of Transgenic Mice Relevant to Major Depression , 2000, Neurochemical Research.
[111] P. Gluckman,et al. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system , 1999, Progress in Neurobiology.